Chris Morabito
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Chris Morabito
Fulcrum Therapeutics, Inc. reported in an 8-K filed July 11, 2022 that Chris Morabito resigned as Chief Medical Officer, effective July 13, 2022.
“On July 8, 2022, Chris Morabito, M.D., Chief Medical Officer of Fulcrum Therapeutics, Inc., or Fulcrum, notified Fulcrum of his resignation from this position and from his employment with Fulcrum, to be effective on July 13, 2022, in order to pursue a new opportunity.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Fulcrum Therapeutics, Inc. (FULC)
Transcript header (unverified)
Start not stated–2022-07-13
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.